HomeMedical SpecialtiesCardiologySunnybrook leads in novel approach to controlling treatment-resistant high blood pressure

Sunnybrook leads in novel approach to controlling treatment-resistant high blood pressure

Published on

With nearly 25 per cent of Canadians living with high blood pressure, Sunnybrook Health Sciences Centre is using a new minimally invasive procedure to help patients reduce their risk of heart attack and stroke.

About a third of those with high blood pressure have ‘uncontrolled hypertension’, a condition in which high blood pressure levels continue despite treatment. Renal denervation is a minimally invasive therapy to safely and effectively reduce blood pressure in patients with uncontrolled hypertension.

The Sunnybrook team uses radio-frequency heat energy, delivered by a catheter, to disrupt electrical signals travelling to and from the kidneys through the renal nerves. Renal nerves help to regulate blood pressure by influencing kidney function; reducing their activity causes blood pressure to lower and become stable in most patients.

“Our first line of treatment if you have high blood pressure is always lifestyle changes, like weight reduction, more physical activity and decreasing alcohol and sodium, in addition to medications,” explains Dr. Mina Madan, interventional cardiologist and medical director of the cardiac catheterization laboratory for Sunnybrook’s Schulich Heart Program. “When this course of action doesn’t sufficiently lower your blood pressure, renal denervation is proving to be an excellent option and a new addition to the toolkit for lowering uncontrolled high blood pressure. In our experience, it has been a safe and effective approach for most patients.”

Since beginning the program in 2023, Dr. Madan and her multidisciplinary team have selected patients with resistant blood pressure who have been taking at least two or three medications to control their blood pressure without success. Following the one-to-two-hour procedure, patients remain in hospital overnight.

To date, 11 patients have been treated, with catheters obtained with support from generous donors to the New Device & Practice Fund at the Sunnybrook Foundation.

“Uncontrolled high blood pressure is one of the leading risk factors for heart disease and premature death. Renal denervation offers a great option for so many who have been taking prescribed medication and it’s just not working,” adds Dr. Madan. “This has the potential to impact thousands of lives in Canada.”

Latest articles

Clinical trial comparing methods of controlling bleeding in cardiac patients

Royal Columbian Hospital is one of 12 North American hospitals involved in a study...

Reducing waitlists for patients with heart valve disease

The Montreal Heart Institute recently opened the MHI’s Heart Valve Centre, a large-scale medical...

Gender bias holds back female surgeons, study finds

From ill-fitting instruments to assumptions about competence, surgical culture sidelines women, first Canadian study...

Melanoma Canada is proud to announce, the Mole Mobile.

Melanoma Canada is proud to announce, the Mole Mobile, mobile skin cancer screening unit on...

More like this

Clinical trial comparing methods of controlling bleeding in cardiac patients

Royal Columbian Hospital is one of 12 North American hospitals involved in a study...

Reducing waitlists for patients with heart valve disease

The Montreal Heart Institute recently opened the MHI’s Heart Valve Centre, a large-scale medical...

AI receptionist answers the call for busy medical clinics

Hospital patients/family members test drive AI phone software co-created by HHS doctor. A Hamilton Health...

World-first clinical trial confirms exercise improves survival for colon cancer

A groundbreaking clinical trial funded by the Canadian Cancer Society (CCS) shows that physical...

Botox at 40: From medical curiosity to a wide range of uses

Originating in a lab in San Francisco in the 1970s, botulinum toxin  –  best...

Canadian first: One-of-a-kind imaging platform for mental health

The Royal has received a $1.9 million grant from Brain Canada to launch a...